<Record>
<Term>Latanoprost</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Organic Chemical</SemanticType>
<ParentTerm>Prostaglandin Compound</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Anti-glaucoma Agent/Latanoprost,/NCIThesaurus/Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Physiology-Regulatory Factor/Eicosanoid/Prostaglandin Compound/Latanoprost</ClassificationPath>
<BroaderTerm>Eicosanoid</BroaderTerm>
<BroaderTerm>Physiology-Regulatory Factor</BroaderTerm>
<BroaderTerm>Anti-glaucoma Agent</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>NCIThesaurus</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Latanoprost</BroaderTerm>
<BroaderTerm>Prostaglandin Compound</BroaderTerm>
<BroaderTerm>Latanoprost,</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Xalatan</Synonym>
<Synonym>LATANOPROST</Synonym>
<Synonym>Latanoprost</Synonym>
<Description>A prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect. Latanoprost increases uveoscleral outflow and thereby reduces intraocular pressure.</Description>
<Source>FDA Registry</Source>
<Source>NCI Thesaurus</Source>
</Record>
